mTESE for men with NOA to determine the decision to initiate ovulation cycles. Methods: From 2012 to 2014, 152 men received diagnostic mTESE procedures. This study had excluded patients with obstructive azoospermia and needle biopsy-confirmed hypospermatogenesis cases. Patients with undescended testis, Klinefelter's syndrome, or Y microdeletion were included. The procedure was performed by Schlegel's method, the testicular tissues were examined under operative microscope up to 24 X. The procedures were started from right testicle, if no sperm found from right side, then left side was opened consequently. The tubules larger than 300 m were sampled for immediate table side touch print smear examination and the tissues were transferred to Bouin's fixatives for further pathological examination. The whole procedure was video-taped for future review. The location of sperm-positive areas was recorded in operation note. The testis wound at tunica albuginea was closed using intra-tunical zipper suture with 6-0 Prolene. Results: Among the 152 patients, the mean sperm retrieval rate was 45.3%. If we included the patients with biopsyconfirmed hypospermatogenesis receiving only therapeutic mTESE, the overall sperm retrieval rate was about 61%. For the patients with positive results at diagnostic mTESE, the sperm retrieval rate at later therapeutic mTESE for ICSI cycle was 100%. For patients who had no sperm found at diagnostic mTESE, they were advised for other options including using donor sperm or adoption. Conclusions: Through this management protocol, up to 55% of infertile couple might avoid the unnecessary ovulation cycle, egg retrieval and the related risks and expenses. The only disadvantage was the necessity for repeat mTESE procedure for infertile men although the subsequent mTESE was significantly time saving, focusoriented and straightforward. 
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AB271. Sexual dysfunction in chronic prostatitis
In-Rae Cho Department of Urology, Inje University Ilsan Paik Hospital, Korea Abstract: Chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS), or NIH category III prostatitis, is a clinical syndrome characterized by genital/ pelvic pain and lower urinary tract symptoms in the absence of urinary tract infection. CPPS is the most common prostatic disease in men younger than 50 years of age and the third most common in men older than 50 years of age. CP/CPPS is a complex entity with unclear etiology. Many articles reported that the high percentage of patients with CP/CPPS had sexual dysfunction. The most common symptoms of sexual dysfunction in chronic prostatitis patients are erectile dysfunction (ED), painful ejaculation and premature ejaculation. So we will discuss about ED and ejaculation problems in CP/CPPS patients. AB272. Penile rehabilitation following radical prostatectomy: practice patterns among Japanese Urological Association members Objective: A compromise in erectile function is commonly experienced after radical prostatectomy (RP). Despite the fact that the benefits are still unclear, penile rehabilitation after RP has become the standard of care for many urologists. Given the lack of definitive proof regarding the benefits, however, a standard program or optimal algorithm does not exist. Furthermore, financial, insurance, and cultural considerations might cause regional differences in the practice of penile rehabilitation. We sought to explore contemporary trends in penile rehabilitation practice patterns of Japanese Urological Association (JUA) members. We also review the epidemiology, rational and current literature on penile rehabilitation after RP. Methods: The proprietary questionnaire was comprised of 35 questions that addressed practitioner demographic factors and current practice status regarding rehabilitation. The questionnaire was mailed to all the representatives of urology departments authorized by the JUA. Results: 376 physicians completed the questionnaire, representing a response rate of 31%. Twenty percent of the responders were members of the Japanese Society for Sexual Medicine (JSSM), 10% had formal sexual medicine specialty training, 68% were urologic oncology specialists, and 91% performed RP. Of the responders, 47% were not aware of the concept of penile rehabilitation and 29% performed some form of rehabilitation. As part of the primary rehabilitation strategy, 97% used phosphodiesterase type 5 inhibitors (PDE5i), 8% used a vacuum device, 13% used intracavernosal injections, and 2% used intraurethral prostaglandin. Twenty percent commenced rehabilitation immediately after urethral catheter removal, and 36% within the first three months after RP. 37%, 21%, and 18% ceased rehabilitation at ≤12, 13-18, and 19-24 months, respectively. With regard to the primary reason for not performing rehabilitation: 52% said they were not familiar with the concept; 22% said patients could not afford it, and 22% gave another reason. Performing rehabilitation was positively associated with being a member of JSSM (P<0.001), seeing post-RP patients (P<0.001), sexual medicine specialty training (P<0.001), being a urologic oncologist (P=0.01), performing RP (P=0.034), and surgeons using the laparoscopic or robotic-assisted approach (P<0.001). Conclusions: Among the respondents, penile rehabilitation is not common. The most commonly employed strategy is PDE5i use and intracavernosal injections were not in common use. Clinicians who are engaged in the field of sexual medicine and see a lot of such patients are more likely to use rehabilitation practice. 
